Identification of CD4+ T cells targeting DM-sensitive antigens presented on mismatched HLA-DP alleles, as mediators of a selective graft-versus-leukemia effect.
Hannah Reimann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Carolin Moosmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Anita N. Kremer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Lisa Denzin(Johnson University), Julia Winkler(SleepMed), Simone Thomas, Heiko Bruns(Friedrich-Alexander-Universität Erlangen-Nürnberg), Andréas Mackensen(University Medical Center Freiburg), Katharina Götz(Universitätsklinikum Erlangen), Anja Wagner(Universitätsklinikum Erlangen), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Vanessa Lang(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 0
Related Papers
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination
|Science Immunology|2022|280
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
|The Lancet Haematology|2019|247
The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts
|Immunity|2021|245
Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells
|Cancer Immunology Immunotherapy|2000|240